TWIST1 and endometrial cancer: Pre-treatment with Twist/ N-cadherin siRNA abolished the protein expression of Twist/ N-cadherin, and cell migration and invasion were decreased, suggesting that the Twist/ N-cadherin signaling pathway may activate cell migration and invasion in endometrial cancer.